The Emerging Role of Bcr-Abl-Induced Cystoskeletal Remodeling in Systemic Persistence of Leukemic Stem Cells

E-ISSN： 1875-5704|11|5|582-591

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.11, Iss.5, 2014-10, pp. : 582-591

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Enhancement of Imatinib-Induced Apoptosis by Matrine in bcr/abl-Positive Leukemia K562 Cells

By Liu Xiao-Shan Jiang JiKai

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 44, Iss. 4, 2006-06 ,pp. : 287-291

Informa Healthcare

Access to resources Recommend Favorite

Alveolar Epithelial Stem and Progenitor Cells: Emerging Evidence for their Role in Lung Regeneration

Current Medicinal Chemistry, Vol. 19, Iss. 35, 2012-12 ,pp. : 6003-6008

Bentham Science Publishers

Access to resources Recommend Favorite

Suppression of Vascular Endothelial Growth Factor (VEGF) Expression by Targeting the Bcr-Abl Oncogene and Protein Tyrosine Kinase Activity in Bcr-Abl-positive Leukaemia Cells

By Li L Zhang R Fang ZY Chen JN Zhu ZL

The Journal of International Medical Research, Vol. 37, Iss. 2, 2009-03 ,pp. : 426-437

Field House Publishing

Access to resources Recommend Favorite

Advances in treatment of chronic myeloid leukemia with tyrosine kinase inhibitors: the evolving role of Bcr–Abl mutations and mutational analysis

By Soverini Simona Martinelli Giovanni Rosti Gianantonio Iacobucci Ilaria Baccarani Michele

Pharmacogenomics, Vol. 13, Iss. 11, 2012-08 ,pp. : 1271-1284

Future Medicine

Access to resources Recommend Favorite

BCR-ABL as a target for novel therapeutic interventions

By Kindler T Meyer RG Fischer T

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 1, 2002-02 ,pp. : 85-101

Informa Healthcare

Access to resources Recommend Favorite